The New Weight-Loss Revolution Is Here—But Not Everyone Will Benefit
Category Details Topic Modern GLP-1 weight-loss medications (Wegovy, Zepbound) Key Breakthrough Up to 20% body weight reduction in clinical settings Best Candidates Patients with obesity or weight-related diseases Main Barriers High cost, access inequality, medical eligibility Key Risk Weight regain after stopping treatment Medical Insight Requires long-term lifestyle integration Expert Voice Physicians emphasize “tool, not … Read more